APOLIPOPROTEIN B DECREASED

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting APOLIPOPROTEIN B DECREASED:

# Drug Count
0 INCLISIRAN 12
1 EZETIMIBE 2
2 DAPAGLIFLOZIN 1
3 METFORMIN 1
4 METFORMIN ER 500 MG 1
5 METFORMIN ER 750 MG 1
6 OMALIZUMAB 1
See all common drugs associated with APOLIPOPROTEIN B DECREASED

APOLIPOPROTEIN B DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INCLISIRAN 12 0.0014
1 EZETIMIBE 2 0.0000
2 DAPAGLIFLOZIN 1 0.0000
3 OMALIZUMAB 1 0.0000
4 METFORMIN ER 500 MG 1 0.0000
See all drugs enriched for association with APOLIPOPROTEIN B DECREASED

These drug classes are most commonly taken by patients reporting APOLIPOPROTEIN B DECREASED:

# Drug class Count
0 Dietary Cholesterol Absorption Inhibitor [EPC] 2
1 Anti-IgE [EPC] 1
2 PCSK9 Inhibitor [EPC] 1
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
See all common drug classes associated with APOLIPOPROTEIN B DECREASED

APOLIPOPROTEIN B DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 PCSK9 Inhibitor [EPC] 1 0.0000
1 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
2 Anti-IgE [EPC] 1 0.0000
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with APOLIPOPROTEIN B DECREASED